Dr. Sulaiman Al Habib Medical Services Group stock
Price history
−17.92% over the period1 year: from SAR 256.20 (November 16, 2025) to SAR 210.30 (November 16, 2026), −17.92%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | SAR 210.30 |
| October 29, 2026 | SAR 221.50 |
| September 30, 2026 | SAR 226.50 |
| August 31, 2026 | SAR 232.90 |
| July 30, 2026 | SAR 235.00 |
| June 30, 2026 | SAR 212.00 |
| May 31, 2026 | SAR 221.00 |
| April 30, 2026 | SAR 242.40 |
| March 31, 2026 | SAR 258.40 |
| February 26, 2026 | SAR 231.00 |
| January 29, 2026 | SAR 261.60 |
| December 31, 2025 | SAR 257.00 |
| November 30, 2025 | SAR 245.00 |
| November 16, 2025 | SAR 256.20 |
At a glance
The company
Provides private healthcare services including hospitals, clinics, pharmacies and medical support services in Saudi Arabia
Latest results
Quarter to September 30, 2026 · EPS SAR 1.95 (estimate SAR 1.90)
TickerLandia's take on Dr. Sulaiman Al Habib Medical Services Group
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 31 vs a median of 42 over its last 6 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 30 vs 17 (+80%) in a group of 11.
- Strong point: Growth (76/100 in its group). Weak point: Market momentum (30/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−21.76% from the 52-week high
Analysts · 14 analysts
Average targetSAR 265.65+26.32% vs. price
Buy 9 · Hold 4 · Sell 1 · Buy
TickerLandia Fingerprint: Dr. Sulaiman Al Habib Medical Services Group
Compared with similar companies: high price, high growth, and low risk.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 46 Middle Eastern stocks.
Pricehigh78
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 29.8 64 Forward P/E 28.3 81 Price/book 8.78 85 Price/sales 4.88 82 EV/EBITDA 23.1 76 Profitabilityhigh69
How much it earns on revenue and capital.
Metric Value Position in group ROE 30.4% 87 ROA 7.4% 55 Gross margin 29.4% 39 Net margin 16.4% 92 Operating margin 18.6% 71 Earnings stabilityhigh72
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.1% 87 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 58 Growthhigh76
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +18.15% 82 Revenue growth (year over year) +18.40% 87 Earnings growth (year over year) +13.20% 61 Financial strengthaverage51
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 7.73 61 Current ratio 1.08 45 Debt/equitycounts in reverse: lower means more financial strength 1.06 39 Net debt/EBITDAcounts in reverse: lower means more financial strength 2.20 61 Dividendhigh67
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 7 years 42 Payout ratio 70.3% 79 Dividend yield 2.6% 79 Market momentumweak30
How the stock has moved compared with the market.
Metric Value Position in group 1-year return −18.92% 25 Distance from 200-day average −8.05% 36 Risklow25
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 22.0% 36 Volatility (60 days) 21.0% 14
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Dr. Sulaiman Al Habib Medical Services Group is cheaper than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Dr. Sulaiman Al Habib Medical Services Group's P/E today is 30.6, below the median of its last 6 fiscal years (41.7; between 36.1 and 48.6 from 2020 to 2025). Dr. Sulaiman Al Habib Medical Services Group's P/E (trailing 12 months): 29.8, +80% against the median of a group of 11 similar companies (16.6).
Compared with 11 similar companies
| Metric | Dr. Sulaiman Al Habib Medical Services Group | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 29.8 | High | |
| Forward P/E | 28.3 | High | |
| Operating margin | 18.6% | Middle | |
| ROE | 30.4% | High | |
| Debt/equity | 1.06 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Dr. Sulaiman Al Habib Medical Services Group. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
SAR 4.1B
Latest quarter · Q3 2026
Net income
SAR 681.6M
Latest quarter · Q3 2026
Quarterly net margin
16.6%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- SAR 74.41B
- P/E
- 29.8
- EPS
- SAR 7.14
- Volume
- 237.5K
- Daily trading
- €14.65M
- Dividend yield
- 2.39%
- Last ex-dividend on November 1, 2026
How Dr. Sulaiman Al Habib Medical Services Group is changing
All resultsRevenue grew 18.5% a year on average over the last 5 years
Operating margin fell from 20.5% to 19.1%
Less cash than profit: free cash flow equal to -10% of net income
Returns
Dr. Sulaiman Al Habib Medical Services Group returns with dividends
SAR 1,000 invested in Dr. Sulaiman Al Habib Medical Services Group 5 years ago, on November 16, 2021, would be worth SAR 1,354 today with dividends reinvested: +35.39% in total, +6.25% per year. On price alone it would be SAR 1,241 (+24.14%).
| Period | Dr. Sulaiman Al Habib Medical Services Group | SAR 1,000 becomes |
|---|---|---|
| 1 month | −5.27% | SAR 947 |
| 6 months | −4.41% | SAR 956 |
| Year to date | −18.17% | SAR 818 |
| 1 year | −16.10% | SAR 839 |
| 3 years | −15.61% | SAR 844 |
| 5 years | +35.39% | SAR 1,354 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Dr. Sulaiman Al Habib Medical Services Group: technical analysis
Dr. Sulaiman Al Habib Medical Services Group is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 37.5% below its all-time closing high (SAR 336.60, February 21, 2024).
- Trend
- Downward
- RSI (14 sessions)
- 39
- Between 30 and 70
- vs 200-session average
- −8.72%
Support and resistance
Price areas where Dr. Sulaiman Al Habib Medical Services Group has stopped several times in the last year. They describe the chart; they are not forecasts.
- ResistanceSAR 219.57+4.41%3 touches, last on September 30, 2026
- ResistanceSAR 215.45+2.45%2 touches, last on May 5, 2026
- ResistanceSAR 211.20+0.43%4 touches, last on July 16, 2026
- Last priceSAR 210.30
- SupportSAR 207.40−1.38%2 touches, last on November 3, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 21.0%
- Largest fall in the last year
- −22.01%
In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Dr. Sulaiman Al Habib Medical Services Group: seasonality
Average monthly price change over 7 years
Over the last 7 years, the strongest month for Dr. Sulaiman Al Habib Medical Services Group has been March: +7.71% on average, positive in 4 years out of 6. The weakest has been May: −2.23% on average, positive in 3 years out of 7. November, the current month, has been positive in 2 years out of 6 (+1.76% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +3.50% | +3.22% | 6 of 6 |
| February | +0.68% | +1.20% | 3 of 6 |
| March | +7.71% | +8.24% | 4 of 6 |
| April | +5.01% | +2.80% | 5 of 7 |
| May | −2.23% | −6.97% | 3 of 7 |
| June | +2.75% | +3.59% | 4 of 7 |
| July | +5.46% | +4.90% | 5 of 7 |
| August | −2.00% | −0.89% | 3 of 7 |
| September | +1.32% | −2.75% | 3 of 7 |
| October | +1.49% | −1.38% | 3 of 7 |
| November | +1.76% | −3.96% | 2 of 6 |
| December | +0.14% | −0.45% | 3 of 6 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Dr. Sulaiman Al Habib Medical Services Group and its competitors
Hospitals and pharmacies stand at the center of Dr. Sulaiman Al Habib Medical Services Group, which delivers private health services across the Kingdom of Saudi Arabia. Through its subsidiaries, the company establishes and runs hospitals, medical complexes and day surgery centers, as well as pharmaceutical facilities. Its supporting services reach from home medical care and specialized laboratories to telemedicine, medical equipment maintenance, revenue cycle management, information technology, facility maintenance and real estate. Its reporting is organized into three segments: healthcare facilities, pharmacies and other solutions.
- Headquarters
- Riyadh, Saudi Arabia
- Employees
- 10,475
- Founded
- 1993
- Chief executive
- Faisal Bin Abdullah Ali Al Nassar
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Dr. Sulaiman Al Habib Medical Services Group4013 | $20.23B | 18.6% | 29.8 | −4.41% |
| Mouwasat Medical Services4002 | $3.23B | 25.8% | 14.0 | −11.07% |
| Tenet HealthcareTHC | $22.76B | 19.1% | 8.37 | +46.04% |
| Encompass HealthEHC | $13.83B | 18.4% | 22.6 | +31.17% |
| Rede D'Or Sao LuizRDOR3 | $13.43B | 20.2% | 16.6 | +0.95% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | $13.05B | 12.1% | 54.4 | +8.52% |
Same industry or related industries, similar size. Compare Dr. Sulaiman Al Habib Medical Services Group with its competitors · Full profile
More on Dr. Sulaiman Al Habib Medical Services Group
- Dr. Sulaiman Al Habib Medical Services Group revenue and financials
- Dr. Sulaiman Al Habib Medical Services Group dividend and valuation
- Dr. Sulaiman Al Habib Medical Services Group stock return
- Dr. Sulaiman Al Habib Medical Services Group employees, headquarters and business
